The largest database of trusted experimental protocols

T8158

Manufactured by Merck Group
Sourced in United States

The T8158 is a laboratory equipment designed for general use in scientific research and analysis. It serves as a versatile tool for various experimental and testing procedures. The core function of this product is to provide a reliable and consistent platform for conducting laboratory-based investigations. A detailed description of the intended use or specialized applications is not available.

Automatically generated - may contain errors

4 protocols using t8158

1

Culturing Rat Kidney Proximal Tubular Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat kidney proximal tubular cells (RPTCs) were originally obtained from Dr Hopfer (Case Western Reserve University) and were cultured in DMEM/F12 medium (12400024; Gibco) containing transferrin (5 μg/mL) (T8158; Sigma), insulin (5 μg/mL) (I9278; Sigma), epidermal growth factor (EGF; 1 ng/mL) (E9644; Sigma), dexamethasone (4 μg/mL) (D1756; Sigma), 10% foetal bovine serum (FBS) (PAN‐Seratech) and 1% antibiotic‐antimycotic (15240062; Thermo Fisher Scientific). RPTC HNF1β knockdown and scramble cell lines were constructed in our previous study.17 Lipofectamine 3000 Transfection Regent (L3000008) was purchased from Thermo Fisher Scientific Company.
About 8‐week‐old C57BL/6J male mice were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd (China). Mice were acclimated for 7 days before formal experiments and were housed in groups of four animals per cage. Animal experiments were performed in accordance with the approval of the Ethics Committee for Experimental Animals in Henan University (Approval Number: DWLL20200102).
+ Open protocol
+ Expand
2

Modulating Intracellular Iron Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to deplete the intracellular iron pool, cells were treated with 30 μM deferoxamine (DFO; D9533, Sigma‐Aldrich) in CDM3 medium, which was added to cells at 0.1 mL/cm2.20To restore intracellular iron levels, cells were incubated with CDM3 medium supplemented with 5 μg/mL partially saturated transferrin (T8158, Sigma‐Aldrich). During experiments, medium was refreshed daily for all conditions.
+ Open protocol
+ Expand
3

Airway Epithelial Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The two-step approach employed a proliferation medium for the liquid-liquid interface stage until day 7, and a differentiation medium for the ALI stage until day 24, as previously described (Chen et al. 2017 (link); Chen and Schoen 2021) (Fig. 1). Both media were formulated on the basis of a basic medium comprising DMEM/Ham's F-12 with 2.5 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin B and 15 mM HEPES. The proliferation medium was the basic medium supplemented with 10 µg/ml insulin (I6634, Sigma-Aldrich, USA), 5 µg/ ml transferrin (T8158, Sigma-Aldrich, USA), 25 ng/ml epidermal growth factor (E4127, Sigma-Aldrich, USA), 0.1 μg/ ml cholera toxin (C8052, Sigma-Aldrich, USA), 30 µg/ml bovine pituitary extract (P1476, Sigma-Aldrich, USA), 5% FBS and freshly added 0.05 μM retinoic acid (R2625, Sigma-Aldrich, USA). The differentiation medium was prepared by supplementing the basic medium with 3% FBS, 2% Nu-Serum growth medium supplement (355100, Corning, USA) and 0.05 μM retinoic acid.
+ Open protocol
+ Expand
4

Progenitor Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD55+/DPP4+ progenitor cultures were maintained and passaged in DMEM with 10 mM Hepes (Gibco, 15630-056), 10% fetal bovine serum (HyClone, SV30160.03), penicillin-streptomycin (50 μg/ml; Thermo Fisher Scientific, 15-140-122), and fibroblast growth factor-2 (2.5 ng/ml; Sigma-Aldrich, F0291-25UG) or differentiated with insulin (5 mg/ml), 0.25 mM dexamethasone, 0.5 mM IBMX, transferrin (10 μg/ml; T8158, Sigma-Aldrich), 0.2 nM triiodothyronine (T6397, Sigma-Aldrich), and 10 mM rosiglitazone. Dexamethasone and IBMX were removed after 2 days, and rosiglitazone was removed after 9 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!